| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Sep 08 '26 | Sale | 49.98 | 1,100 | 54,978 | 106,566 | Sep 09 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Sep 01 '26 | Sale | 50.50 | 1,100 | 55,550 | 107,666 | Sep 02 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Aug 25 '26 | Sale | 50.06 | 1,100 | 55,066 | 108,766 | Aug 26 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Aug 18 '26 | Sale | 48.68 | 1,100 | 53,548 | 109,866 | Aug 19 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Feb 27 '26 | Option Exercise | 0.00 | 100,287 | 0 | 128,023 | Mar 03 |
| DXCM | Malady Kyle | Director | Sep 05 '25 | Sale | 80.86 | 667 | 53,934 | 22,667 | Sep 09 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | May 08 '25 | Sale | 43.81 | 10,000 | 438,102 | 8 | May 09 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | May 07 '25 | Sale | 44.10 | 9,000 | 396,900 | 10,008 | May 08 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Apr 30 '25 | Sale | 43.88 | 7,500 | 329,063 | 19,008 | May 01 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Apr 24 '25 | Sale | 43.02 | 10,000 | 430,240 | 26,508 | Apr 25 |
| VZ | Malady Kyle | EVP and Group CEO-VZ Business | Apr 23 '25 | Sale | 42.48 | 5,000 | 212,425 | 36,508 | Apr 24 |